[Effect of nonachlazine on the calcium mechanism of regulating coronary artery tone].
D000818:Animals; D002118:Calcium / Q000037:antagonists & inhibitors* / Q000378:metabolism; D003331:Coronary Vessels / Q000187:drug effects*; D000242:Cyclic AMP / Q000378:metabolism; D004285:Dogs; D004347:Drug Interactions; D066298:In Vitro Techniques; D009131:Muscle, Smooth, Vascular / Q000378:metabolism; D009628:Nonachlazine / Q000008:administration & dosage / Q000494:pharmacology*; D010208:Papaverine / Q000008:administration & dosage; D010640:Phenothiazines / Q000494:pharmacology*; D011433:Propranolol / Q000008:administration & dosage; D011943:Receptors, Adrenergic, beta / Q000187:drug effects
D010640:Phenothiazines; D011943:Receptors, Adrenergic, beta; D009628:Nonachlazine; D011433:Propranolol; D010208:Papaverine; D000242:Cyclic AMP; D002118:Calcium
Deĭstvie nonakhlazina na kal'tsievyĭ mekhanizm reguliatsii tonusa koronarnykh arteriĭ.